HDL

SUPER HI INTERNATIONAL HOLDING

$12.33

+$0.00 (+0.00%)Today

Key Statistics

Market cap725.46M

Price-Earnings ratio24.66

Dividend yield—

Average volume360

High today$12.33

Low today$12.33

Open price$12.33

Volume227

52 Week high$21.20

52 Week low$12.00

Company Profile

Description

Super Hi International Holding Ltd., an investment holding company, engages in the restaurant operation and delivery business in Asia, North America, Europe, Oceania, and internationally. It owns and operates Haidilao restaurants. The company also offers food delivery services; and sells hot pot condiment products and food under the Haidilao brand and secondary brands to local guests and retailers. The company was incorporated in 2022 and is headquartered in Singapore.

Sector

Consumer Cyclical

Industry

Restaurants

CEO

Mr. Yu Li

Website

superhiinternational.com

Company Profile

Description

Sector

Consumer Cyclical

Industry

Restaurants

CEO

Mr. Yu Li

Website

superhiinternational.com

HDL

Key Statistics

Company Profile

Company Profile

Recent News

ABIONYX Pharma: Half-Year Review of the Liquidity Agreement Entered into with TP ICAP (Europe) SA

Architecting the Future of HR Tech: The Rise of Anusha Atluri in Oracle Cloud Innovation

Engineering with Empathy: A Deep-Dive Interview with Anusha Atluri on Building Human-Centric Oracle Cloud Systems

ABIONYX Pharma is Scaling up Its Operations After Securing the Resources Needed to Achieve Its Goals and Is Embarking on a New Cycle of Value Creation in the Treatment of Severe Inflammation and Sepsis

Get Off Your Butt. After Sitting 8 Hours, You Need to Do This.

What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management

Cognito Therapeutics to Present New Data Highlighting Effects of Spectris™ on Lipid Transport Biomarkers in Alzheimer’s Disease at AAIC 2026

ABIONYX Pharma Announces the Success of its Financing for a Total Maximum Amount of EUR 33 M

Recent News

Company Profile

Recent News

ABIONYX Pharma: Half-Year Review of the Liquidity Agreement Entered into with TP ICAP (Europe) SA

Architecting the Future of HR Tech: The Rise of Anusha Atluri in Oracle Cloud Innovation

Engineering with Empathy: A Deep-Dive Interview with Anusha Atluri on Building Human-Centric Oracle Cloud Systems

ABIONYX Pharma is Scaling up Its Operations After Securing the Resources Needed to Achieve Its Goals and Is Embarking on a New Cycle of Value Creation in the Treatment of Severe Inflammation and Sepsis

Get Off Your Butt. After Sitting 8 Hours, You Need to Do This.

What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management

Cognito Therapeutics to Present New Data Highlighting Effects of Spectris™ on Lipid Transport Biomarkers in Alzheimer’s Disease at AAIC 2026

ABIONYX Pharma Announces the Success of its Financing for a Total Maximum Amount of EUR 33 M